Inogen, Inc. Home

Inogen 2025 First Quarter Financial Results

May 7, 2025 - 2:00 pm PT

Event Details Webcast

Latest News

Inogen to Report First Quarter 2025 Financial Results on May 7, 2025

Read Press Release View All

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Upcoming Events

May 7, 2025 • 2:00pm PDT

Inogen 2025 First Quarter Financial Results

View Event View All Events

Latest Presentation

2025-01-13

Company Overview

Download View All

Latest Financial Results

FY 2024

Fiscal Year Ended Dec 31, 2024

>$335M Total full-year 2024 revenue of $335.7 million
>46% Total full-year 2024 gross margin of 46.1%
>$80M Total fourth quarter 2024 revenue of $80.1 million

For complete information regarding our financials, see our periodic filings

Annual Reports & Proxy Statements

2024 Annual Report Inogen 2025 Proxy Statement

Inogen 2025 Annual Meeting of Shareholders

May 14, 2025 • 10:00am PDT

Sign up for Email Alerts

Give Me Alerts

Stock Information

Inogen, Inc.

View Presentation

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the impact of their disease.

View Company Profile

2024 Revenue Breakdown

2023 Revenue Breakdown

Products

Inogen Rove 6® product image

Inogen Rove 6®

  • 6 pulse dose settings
  • 4.8 pounds
  • Battery life up to 12 hours and 45 minutes
  • Technology clinically validated for 24/7 use
  • Meets FAA requirements
Inogen® Rove 4™ product image

Inogen® Rove 4™

  • 4 pulse dose settings
  • 2.9 pounds with standard battery
  • Battery life up to 5 hours and 45 minutes with extended battery
  • Meets FAA requirements1
  • Technology clinically validated for 24/7 use2

1. Based on Technical Performance Data. Check with your carrier for local regulations.
2. With access to power

Inogen One G4® product image

Inogen One G4®

  • 3 flow settings
  • 2.8 pounds
  • Battery life up to 5 hours
  • Meets FAA requirements
  • Technology clinically validated for 24/7 use
Inogen At Home® product image

Inogen At Home®

  • 5 liters per minute, continuous flow
  • Only 18 pounds
  • Extremely quiet
  • Energy-efficient
  • Only 100W on Flow Setting 2

A Team Built for Success

Our leadership team is focused on strengthening the Inogen brand via expanding awareness of our innovative solutions as well as growing across our consumer and business sales channels.

View Management Team View Board of Directors